Management of Persons with Latent Tuberculosis Infection (LTBI)

Section 696 Section 696.150  Management of Persons with Latent Tuberculosis Infection (LTBI) a)         Treatment for LTBI.  Persons with a positive TB screening test result shall complete a diagnostic evaluation for active TB disease.    If there is no evidence of active TB disease, persons with LTBI shall be considered for treatment.  Treatment for LTBI shall be conducted in accordance with the CDC guidelines Targeted Tuberculin Testing and Treatment of Latent TB Infection. b)         Monitoring for Adverse Medication Reaction.  At a minimum, patients shall be monitored monthly during therapy and evaluated for adverse medication reactions.